In September 2026, leading U.S. cannabis companies Cresco Labs, Trulieve Cannabis, and Green Thumb Industries demonstrated significant growth and strategic expansion. Cresco Labs strengthened its position in Pennsylvania with a $50 million acquisition and reported improved financials including $173 million in Q2 revenue. Trulieve expanded its dispensary network, especially in Florida, and began trading on the NYSE, reporting $271 million in Q2 revenue despite a large accounting loss. Green Thumb Industries posted the highest quarterly revenue at $306.7 million, expanded in Pennsylvania and Florida, and announced a $50 million share repurchase program. These developments highlight the evolving cannabis market and the importance of profitability, cash flow, and market presence for investors.
The story covers three cannabis stocks to watch heading out of September. For readers following the health sector, here is Pluang's market snapshot as of Sep 29, 2026 20:32 WIB: out of 100 priced US health-sector stocks, 26 rose and 69 fell. Mesoblast Limited (MESO) traded at USD 14.74 with a 1-day gain of +1.66% and a typical hold time of 13 days, contrasting with Citius Pharmaceuticals Inc (CTXR) at USD 0.54 which fell by -1.62% but saw 100% buy order activity and a typical hold time of 16 days. Intuitive Surgical, Inc. (ISRG) was priced at USD 408.17, down -1.60% with a much longer hold time of 85 days and a nearly balanced buy/sell order split.
Netflix shares rose 1.5% after Deutsche Bank upgraded the stock from Hold to Buy, citing recent price declines as a buying opportunity and stronger international trends. However, other analysts remain cautious, with Wells Fargo downgrading Netflix to...
Cytokinetics' CEO Robert I. Blum and other executives have recently sold large amounts of company stock, with Blum selling nearly 105,000 shares in total, including a major block under a pre-arranged trading plan. This insider selling occurs while th...
Carnival Corporation reported strong quarterly results with earnings per share of $1.43 and net income of $1.92 billion, surpassing analyst expectations. The company achieved record revenue of $8.44 billion, driven by growing consumer interest in cru...
FactSet is set to report strong Q3 earnings with an expected EPS of $4.35 and revenue around $629.83 million, reflecting a 5.3% increase from last year. The company benefits from high demand for AI-related products, expanded client base, and effectiv...
Jefferies Financial Group reported robust Q3 results with earnings per share of $1.09, beating analyst estimates and last year's $1.05. Revenue rose to $2.22 billion, driven by record banking revenue, surpassing expectations. Net earnings increased t...
